Ernexa Therapeutics Inc.
ERNA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000748592
No open-market purchases or sales by Ernexa Therapeutics Inc. insiders were filed in the last 90 days; 10 institutions reported holding it in 13F filings for Q2 2026, worth $236.2K in total; no superinvestor holds it.
Other share classesERNAW
13F holders, Q4 2022
Institutional positions in Ernexa Therapeutics Inc. as of Dec 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 20
- +20 vs. Q3 2022
- Shares held
- 330.0K
- +330.0K vs. Q3 2022
- Total value
- $1.19M
- +$1.19M vs. Q3 2022
- New holders
- 20
- 0 more added
- Sold out
- 0
- 0 more reduced
Compare with Q3 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ERNA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 10 | $236.2K |
| Q1 2026 | 20 | $711.4K |
| Q4 2025 | 14 | $627.1K |
| Q3 2025 | 14 | $566.0K |
| Q2 2025 | 12 | $91.7K |
| Q1 2025 | 27 | $264.2K |
| Q4 2024 | 24 | $292.4K |
| Q3 2024 | 20 | $746.9K |
| Q2 2024 | 20 | $712.4K |
| Q1 2024 | 23 | $981.1K |
| Q4 2023 | 20 | $636.9K |
| Q3 2023 | 22 | $728.4K |
| Q2 2023 | 20 | $750.2K |
| Q1 2023 | 21 | $1.14M |
| Q4 2022 | 20 | $1.19M |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q4 2022
Shares, value and share of portfolio for each institution holding Ernexa Therapeutics Inc.; share changes are against Q3 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| JPMorgan Chase & Co | 14 | $0 | 0.00% | +14 | New |
| Tower Research Capital LLC (TRC) | 205 | $0 | 0.00% | +205 | New |
| FMR LLC | 1 | $3 | 0.00% | +1 | New |
| Bank of America Corp | 9 | $29 | 0.00% | +9 | New |
| Aspire Private Capital, LLC | 10 | $32 | 0.00% | +10 | New |
| Citigroup Inc | 15 | $48 | 0.00% | +15 | New |
| Group One Trading, L.P. | 19 | $61 | 0.00% | +19 | New |
| Wells Fargo & Company | 26 | $84 | 0.00% | +26 | New |
| Montag A & Associates Inc | 70 | $225 | 0.00% | +70 | New |
| Carmichael Hill & Associates, Inc. | 75 | $242 | 0.00% | +75 | New |
| Credit Suisse AG | 120 | $386 | 0.00% | +120 | New |
| Morgan Stanley | 1,363 | $4.39K | 0.00% | +1,363 | New |
| Baldwin Brothers Inc | 9,192 | $29.6K | 0.00% | +9,192 | New |
| Geode Capital Management, LLC | 13,985 | $45.0K | 0.00% | +13,985 | New |
| Renaissance Technologies LLC | 17,536 | $56.0K | 0.00% | +17,536 | New |
| BlackRock Inc. | 23,141 | $74.5K | 0.00% | +23,141 | New |
| Vanguard Group Inc | 29,068 | $93.6K | 0.00% | +29,068 | New |
| CI Private Wealth, LLC | 61,189 | $197.0K | 0.00% | +61,189 | New |
| Cypress Point Wealth Management, LLC | 94,375 | $303.9K | 0.48% | +94,375 | New |
| Naviter Wealth, LLC | 79,621 | $387.0K | 0.11% | +79,621 | New |